Friedel, Evelyn B. N. http://orcid.org/0000-0001-9862-9656
Hahn, Hannah-Tabea
Maier, Simon
Küchlin, Sebastian
Reich, Michael
Runge, Kimon http://orcid.org/0000-0002-0263-4360
Bach, Michael http://orcid.org/0000-0003-2028-535X
Heinrich, Sven P. http://orcid.org/0000-0003-4906-3937
Kornmeier, Jürgen
Endres, Dominique http://orcid.org/0000-0001-7322-1195
Ebert, Dieter
Domschke, Katharina http://orcid.org/0000-0002-2550-9132
Tebartz van Elst, Ludger http://orcid.org/0000-0002-2274-5447
Nickel, Kathrin http://orcid.org/0000-0001-9863-317X
Article History
Received: 24 February 2022
Revised: 6 September 2022
Accepted: 8 September 2022
First Online: 23 September 2022
Competing interests
: KD: member of the ‘Steering Committee Neurosciences’, Janssen Pharmaceuticals, Inc., LTvE: Advisory boards, lectures, or travel grants within the last 3 years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen and Cyberonics. The remaining authors declare no competing interests.